Cardiol Therapeutics Inc.
NASDAQ:CRDL
1.25 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.062 | 0.062 | 0.067 | 0.065 | 0.058 | 0.058 | 0.058 | 0.054 | 0.054 | 0.054 | 0.056 | 0.056 | 0 | 0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.062 | -0.062 | -0.067 | -0.065 | -0.058 | -0.058 | -0.058 | -0.054 | -0.054 | -0.054 | -0.056 | -0.056 | 0.079 | -0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.751 | 2.71 | 3.323 | 4.04 | 2.577 | 3.479 | 4.128 | 5.618 | 5.089 | 4.407 | 3.848 | 3.528 | 2.592 | 1.9 | 2.609 | 7.212 | 1.901 | 0.818 | 0.584 | 1.031 | 1.238 | 0.748 | 0.513 | 0.281 | 0.447 | 0.548 | 0.256 | 0.117 | 0.11 | 0.214 |
| General & Administrative Expenses
| 10.39 | 5.032 | 5.083 | 3.988 | 5.079 | 2.835 | 3.658 | 3.477 | 8.131 | 4.825 | 5.941 | 9.57 | 7.572 | 4.548 | 6.316 | 2.348 | 2.453 | 2.708 | 2.436 | 2.21 | 2.307 | 2.968 | 2.963 | 2.969 | 1.966 | 0.679 | 0.256 | 0.433 | 0.381 | 0.111 |
| Selling & Marketing Expenses
| 0 | 0 | -0.062 | 3.918 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.061 |
| SG&A
| 10.39 | 5.032 | 5.021 | 3.922 | 5.079 | 2.835 | 3.658 | 3.477 | 8.131 | 4.825 | 5.941 | 9.57 | 7.572 | 4.548 | 6.316 | 2.348 | 2.453 | 2.708 | 2.436 | 2.21 | 2.307 | 2.968 | 2.963 | 2.969 | 1.966 | 0.679 | 0.256 | 0.433 | 0.381 | 0.172 |
| Other Expenses
| 0 | 0 | 0.028 | 0 | 0.15 | 0 | 0 | 0 | 0.164 | 0 | 0 | 0.019 | 0.093 | 0 | 0 | 0 | 0 | 0 | 0.007 | 0.219 | 0 | 0.08 | 0 | 0 | -0.268 | 0 | 0 | -0.018 | -0.022 | 0 |
| Operating Expenses
| 14.14 | 7.741 | 8.344 | 7.962 | 7.656 | 6.315 | 7.786 | 9.095 | 13.22 | 9.232 | 9.788 | 13.098 | 10.164 | 6.502 | 8.98 | 9.619 | 4.411 | 3.584 | 3.077 | 3.291 | 3.584 | 3.754 | 3.499 | 3.274 | 2.436 | 1.25 | 0.535 | 0.571 | 0.507 | 0.43 |
| Operating Income
| -14.14 | -7.741 | -8.405 | -8.029 | -7.656 | -4.629 | -7.937 | -10.09 | -17.915 | -11.784 | -10.551 | -19.891 | -10.288 | -6.26 | -9.034 | -9.599 | -4.387 | -3.57 | -3.05 | -3.031 | -3.523 | -3.607 | -3.423 | -3.214 | -2.396 | -1.248 | -0.533 | -0.565 | -0.507 | -0.401 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -79.484 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.412 | 1.15 | -0.774 | 0.392 | 1.726 | -1.157 | 0.697 | 1.58 | 5.248 | 2.743 | 0.834 | 6.84 | 0.254 | -0.138 | 0.07 | -0.048 | 0.01 | -0.054 | 0.101 | -0.106 | 0.031 | -0.036 | -0.068 | -5.86 | -2.514 | -0.111 | -0.019 | -0.017 | -0.028 | -0.057 |
| Income Before Tax
| -12.728 | -6.591 | -9.18 | -7.637 | -5.93 | -7.472 | -7.089 | -7.515 | -7.972 | -6.489 | -8.954 | -6.257 | -9.91 | -6.561 | -8.91 | -9.667 | -4.401 | -3.625 | -2.949 | -3.059 | -3.492 | -3.643 | -3.491 | -9.074 | -4.91 | -1.358 | -0.552 | -0.588 | -0.536 | -0.443 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -83.303 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0 | -0 | -1.576 | 1.157 | -0.697 | -1.58 | -5.084 | -2.743 | -0.834 | -6.821 | -0.161 | 0.138 | -0.07 | 0 | 0 | 0 | 0.007 | 0.219 | 0 | 0.08 | 0.001 | 0.269 | 0.268 | 0.108 | 0 | 0.018 | 0.022 | 0 |
| Net Income
| -12.728 | -6.591 | -9.18 | -7.637 | -5.93 | -7.472 | -7.089 | -7.515 | -7.972 | -6.489 | -8.954 | -6.257 | -9.91 | -6.561 | -8.91 | -9.667 | -4.401 | -3.625 | -2.949 | -3.059 | -3.492 | -3.643 | -3.491 | -9.074 | -4.91 | -1.358 | -0.552 | -0.588 | -0.536 | -0.443 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -83.303 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0 | -0.096 | -0.14 | -0.12 | -0.092 | -0.12 | -0.11 | -0.12 | -0.13 | -0.1 | -0.14 | -0.11 | -0.23 | -0.16 | -0.26 | -0.29 | -0.13 | -0.13 | -0.11 | -0.12 | -0.13 | -0.14 | -0.14 | -0.4 | -0.22 | -0.06 | -0.024 | -0.026 | -0.024 | -0.034 |
| EPS Diluted
| 0 | -0.096 | -0.14 | -0.12 | -0.092 | -0.12 | -0.11 | -0.12 | -0.13 | -0.1 | -0.14 | -0.11 | -0.23 | -0.16 | -0.26 | -0.29 | -0.13 | -0.13 | -0.11 | -0.12 | -0.13 | -0.14 | -0.14 | -0.4 | -0.22 | -0.06 | -0.024 | -0.026 | -0.024 | -0.034 |
| EBITDA
| -13.939 | -7.679 | -8.344 | -7.962 | -7.609 | -6.256 | -7.728 | -9.077 | -13.166 | -9.178 | -9.735 | -13.082 | -10.108 | -6.369 | -8.926 | -9.6 | -4.353 | -3.513 | -2.993 | -3.009 | -3.452 | -3.605 | -3.467 | -3.19 | -2.373 | -1.228 | -0.51 | -0.548 | -0.498 | -0.393 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -78.791 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |